Table 3 Angiographic characteristics of CAD patients
From: The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
Variable | PlA1 (n = 300) | PlA2 (n = 100) | p Value |
|---|---|---|---|
Coronary artery disease (%) | |||
LAD | 61.9 | 50 | 0.27 |
Cx | 33.6 | 29 | 0.37 |
Dx | 45 | 50 | 0.30 |
Multivessel Disease (%) | 28 | 30 | 0.49 |
Lesion type, B2/C (%) | 78 | 85 | 0.55 |
BMS (%) | 74 | 66 | 0.56 |
DES (%) | 26 | 34 | 0.57 |
TIMI 3 post PCI (%) | 97.5 | 98 | 0.89 |
cTFC post (mean ± SD) | 15.10 ± 6 | 14.25 ± 8 | 0.76 |
Lesion length (mm) | 15.54 ± 6.59 | 16.48 ± 8.74 | 0.13 |
Preprocedural stenosis (%) | 86.55 ± 10.19 | 85.05 ± 11.48 | 0.11 |
Stent/patient (n) | 1.08 ± 0.32 | 1.07 ± 0.26 | 0.74 |